FIS
51
-4
WM
74
-5
HSY
31
-6
PLD
45
-5
PAYX
48
-6
CI
45
-3
VRTX
47
-6
MU
28
-3
TGNA
50
-6
WAT
48
-11
TXN
43
-5
SBUX
37
-2
CAT
59
-2
PBI
56
-2
ADP
65
-3
EXC
54
3
DHR
32
-6
VZ
44
4
RHI
57
-6
ETR
65
2
FIS
51
-4
WM
74
-5
HSY
31
-6
PLD
45
-5
PAYX
48
-6
CI
45
-3
VRTX
47
-6
MU
28
-3
TGNA
50
-6
WAT
48
-11
TXN
43
-5
SBUX
37
-2
CAT
59
-2
PBI
56
-2
ADP
65
-3
EXC
54
3
DHR
32
-6
VZ
44
4
RHI
57
-6
ETR
65
2
Financhill
Back

iShares Core Conservative Allocation ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
41

AOK
iShares Core Conservative Allocation ETF

Last Price:
37.69
Seasonality Move:
0.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.82
Seasonality Move:
17.03%
Sell
41
iShares Core Conservative Allocation ETF (AOK) is a Sell

Is iShares Core Conservative Allocation ETF a Buy, Sell or Hold?

  • The current iShares Core Conservative Allocation ETF [AOK] share price is $37.69. The Score for AOK is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AOK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AOK Stock Price Chart

What is iShares Core Conservative Allocation ETF's stock price today?

  • The iShares Core Conservative Allocation ETF share price today is $37.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AOK is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AOK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.76 Sell
Chaikin Money Flow: -5135 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.78 - 38.2) Sell
Bollinger Bands (100): (37.34 - 38.34) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AOK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.92 Sell
20-day SMA: 37.9 Sell
50-day SMA: 38.19 Sell
200-day SMA: 37.13 Buy
8-day EMA: 37.85 Sell
20-day EMA: 37.94 Sell
50-day EMA: 38 Sell
200-day EMA: 37.2 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares Core Conservative Allocation ETF Earnings Growth & AOK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

iShares Core Conservative Allocation ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):